Mono Pharmacare Limited
₹40.85
+2.12%
Delayed · cached 15 min
Fair value analysis
MONOPHARMA
Mono Pharmacare Limited
₹8.95
Close used for this calculation
₹5.31Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
24/100
Quality radar
Consensus fair value
₹5.31
Above FV▼ -40.7% against the close used
Model range ₹1.97 – ₹8.89
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₹1.97Fair value₹5.31Bull₹8.89
FairClose
52-week traded range
52W low ₹7.6052W high ₹24.45
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Mono Pharmacare Limited closed at ₹8.95, 68.5% above the consensus fair value of ₹5.31 drawn from 6 valuation models.
Financial DNA score 24/100 — Weak. P/E of 45.2x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₹3.75
-58.1%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₹8.89
-0.7%
√(22.5 × EPS × BVPS)
EPS=0.2, BVPS=17.55 · outside Graham range (P/E 45.2, P/B 0.5) — asset-light, treat as a rough floor
P/E Fair Value
₹7.14
-20.2%
EPS × 35.7x (sector P/E)
EPS=0.2, Sector P/E=35.7x
Book Value (P/B)
₹1.97
-78.0%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=17.55, ROE=1.1%, g=3%, r=10%
Reverse DCF
₹8.95
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 18% | Historical: 0%
Margin of Safety
₹4.95
-44.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=6.59, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.